oral cancers by dr. sintayehu sirino

219
banner4-1.jpg

Upload: sentayehu-serino

Post on 13-Apr-2017

323 views

Category:

Education


0 download

TRANSCRIPT

Page 1: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

banner4-1.jpg

Page 2: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

CONTENTS✓ Tumorsofso)*ssues✓ Epithelial✓ Connec2ve2ssue✓ Vascular✓ Nerve2ssue✓ Salivaryglands✓ Tumorsofhard*ssues✓ Nonodontogenictumors✓ Diseasesofsalivaryglands

Page 3: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

•  Objec*vesAttheendeachstudentsshouldknow•  Whatdowemeanbytumors•  Whatdowemeanbyso?andhard2ssues•  Tumorsofso?2ssues•  Tumorsofhard2ssues•  Somediseasesofsalivaryglands

Page 4: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

EPITHELIALTUMORS•  Papilloma…..benigntumor•  carcinoma…...malignanttumor/cancer•  Melanoma…...malignanttumor

Page 5: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

EpithelialtumorsA.PapillomaDefini*on➢ Papillomaisabenigntumorknowntogrowinanoutwarddirec*on,itproducesfrond-liketumorsthatcandevelopanywhereonthebody.

➢ Papillomaarealsoknownasneoplasms.➢ Papillomacanoccurinareasthroughoutthebody.➢ Papillomaontheskin(cutaneouspapilloma)arecommonlyreferredtoaswarts.

Page 6: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Etiology"  Viral

HPV"  Nonviral

Tissueinjury…...Nasalpapilloma

Page 7: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

CLINICALFEATURES

•  Commonbenignneoplasmorigina*ngfromsurfaceepithelium

•  Exophy*cgrowthmadeoffingerlikeprojec*ons

•  Roughened,Verrucousorcauliflowerlikeappearance

•  Wellcircumscribed,pedunculated,•  Foundontongue,lips,buccalmucosa,

gingiva&palate•  Fewmmsindiametertoseveralcms

Page 8: ORAL CANCERS BY Dr. SINTAYEHU SIRINO
Page 9: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

•  Mul*plepapillomasareseeninfocaldermalhypoplasiasyndrome

Page 10: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

•  Treatment -Excisionthroughthepedicle

Page 11: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

carcinomasquamouscellcarcinoma

basalcellcarcinoma

Page 12: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

SquamousCellCarcinoma

•  Defined as amalignant epithelial neoplasmexhibi*ng squamous differen*a*on ascharacterized by the forma*on of kera*nand/orthepresenceofintracellularbridges.

Page 13: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Epidemiology

•  SoutheastAsianscenario-•  6,44,600in19992•  Na*onalcancerRegistryProgramme

Page 14: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

E*ology

•  UnequivocallyassociatedwithTobaccochewinghabits&usuallyprecededbypremalignantlesions&condi*ons.

•  Alcohol•  Syphilis•  Nutri*onaldeficiencies•  Sunlight•  Miscellaneous-Trauma,irita*on•  Viruses-HPV,

Page 15: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Carcinomaoflip

•  Occurschieflyinelderlymen•  Lowerlipinvolvedmorecommonly•  Greatestincidencebetween55-75years

Page 16: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

E*ology

•  Tobacco•  Leukoplakia

Page 17: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

•  Vermillonborderoflip•  Smallareaofindura*on,ulcera*onorirregularity

•  Smallcrater-likedefect•  Slowmetastasistoipsilaterallymphnodes

Page 18: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatmentandprognosis

•  Surgicalexcision•  X-rayradia*on

•  Factorsaffec*ngsuccessoftreatment•  Sizeoflesion•  Dura*on•  Metastases•  Histologicgrade

Page 19: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Carcinomaoftongue

•  Comprises25-50%ofintraoralcancer•  Lesscommoninwomen•  Averageagerange32-87years

Page 20: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

E*ology

•  Syphilisseenco-existentwithcarcinoma•  Leukoplakia•  Poororalhygiene•  Chronictrauma•  Alcoholtobacco

Page 21: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

•  Painlessmassorulcer•  Painfulifsecondarilyinfected•  Lateralborderorventralsurfaceoftongue•  Ifinposteriorpor*onoftongue-causeearlymetastases&poorprognosis

Page 22: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment&prognosis

•  Judiciouscombina*onofsurgery&X-rayradia*on

Page 23: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Carcinomaoffloorofmouth

•  Clinicalfeatures•  Induratedulcer•  Mayormaynotbepainful•  Anteriorpartmoreo)eninvolved•  Earlyextensionintolingualmucosa•  Limitsmo*onoftongue•  Metastasestosubmaxillarylymphnodes

Page 24: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment&prognosis

•  X-rayradia*on•  Useofradium

Page 25: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

CarcinomaofbuccalmucosaE*ology-"  tobaccochewing&carryingbetelnutquid

•  LeukoplakiaClinicalfeatures•  Alongorinferiortoalineoppositeocclusalplane

•  Highrateofmetastases

Page 26: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment&prognosis

•  SurgeryorX-rayradia*on•  Prognosisdependsonprescenceofmetastases

Page 27: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Carcinomaofgingiva

•  Morecommoninmandibulargingiva•  Anareaofulcera*on,erosion,orexophy*cgrowthTreatment&prognosis-Surgicalexcision

Page 28: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Carcinomaofpalate

•  Manifestsasapoorlydefined,ulcerated,painfullesionononesideofmidline

Treatment&prognosisBothsurgery&radia*onhavebeenused.

Page 29: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

MELANOMA

•  Akamalignantmelanoma•  Isatypeofcancerthatdevelopsfromthepigmentcontainingcellsknownasmelanocyteswhicharelocatedbetweenepidermisanddermis

•  Typicallyoccurintheskinbutmayrarelyoccurinthemouth,intes*neandeyes

Page 30: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

•  Neoplasmofepidermalmelanocytes.•  Cutaneousmelanomasareincreasinginincidence.•  Among dark skinned ethics it 1 per 100,000 and inlight-skinnedupto50andhigherinsomeareasoftheworld.

•  Melanoma may occur or near a previously exis*ngprecursorlesionorinhealthyappearingskin.

Page 31: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Etiology

•  A)environmentalfactors:•  Sunexposure•  Ar*ficialUVsources•  Socioeconomicstatus•  Fairskin,frecklesandredhair•  Numberofmelanocy*cnevi•  B)gene*cfactors:•  Familialmelanoma•  Xerodermapigmentosum

Page 32: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

ClinicalfeaturesSuperficialspreadingmelanoma:•  CommoncutaneousmelanomainCaucasians.•  Existsinaradial-growthphasecalledpremalignantmelanosisorpagetoidmelanomainsitu.

•  Thever*calgrowthphaseischaracterizedbyanincreaseinsize,changeincolor,nodularity,ulcera*on.

Page 33: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Nodularmelanoma:•  Accountsforapproximately13percentofcutaneousmelanomas.

•  Noclinicallyrecognizableradial-phasegrowth,existssolelyinver*cal-growthphase.

•  Theymaybepink(amelano*cmelanoma)orpink.

•  Predilec*onforbackandheadandneckskinofmen.

Page 34: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Len*gomalignamelanoma:•  Accountsfor10percentofcutaneousmelanomas.

•  Existsinaradial-growthphaseknownaslen*gomalignaormelano*cfreckleofhutchinson.

•  Showsfemalepredilec*on.

Page 35: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Acrallen*ginousmelanomas:•  Melanomadevelopingonthepalmsandsoles,fingersandtoes.

•  Thetumorischaracterizedbymacular,len*ginouspigmentedareaaroundanodule.Mucosallen*ginousmelanomas:•  Developfrommucosalepitheliumthatlinestherespiratory,gastrointes*nalandgenitourinarysystems.Noncutaneousmelanomasarecommoninolderage.

•  Len*gomelanomashaveaggressivecourse.

Page 36: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Amelano*cmelanomas•  Seenaserythematousorpink,erodednodule.

Page 37: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Oralmanifesta*ons:•  Primaryoralmelanomatwiceascommoninmen.•  Israngebetween40-70years.•  Predilec*onforpalateandmaxillaryalveolarridge.

•  Appearsasdeeplypigmentedareas.•  Ulceratedandhemorrhagic.•  Increaseinsizeprogressively.

Page 38: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment

Beforeithasspread• surgery

A)erhasspread• Immunotherapy• Biologictherapy• Radia*ontherapy• Chemotherapy

Page 39: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

CONNECTIVETISSUETUMORS•  Fibroma……...benigntumor•  Lipoma……….benigntumor•  fibrosarcoma...malignanttumor

Page 40: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Fibroma

"  Benigntumorsthatarecomposedoffibrous"  Akairritationfibroma

•  Theyusuallyemergeinthecheeks,tongue,palateandgums.

•  Fibroidsusuallygrowveryslowly

Page 41: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Etiology"  Unknowncauses"  Tissuerxntominorinjury"  Geneticcomponents

Page 42: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

•  Epulisfissuratum•  Sessileorpedunculated•  Asymptomaticandmoderatelyfirm•  Whitenessfromthethickenedsurfacekeratin•  Ulcerationfromrecurringtrauma

Page 43: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Differentialdiagnosis

PyogenicgranulomaNeurofibromafrictionalkeratosissquamouscellcarcinoma

Page 44: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment• Conservativesurgicalexcision• Itmayrecura)ersurgeryifthesourceofirrita*oncon*nuessomanagethesourceofirritation

• Oralfibromasdonotdisappearwithouttreatment.

Page 45: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Lipoma

"  Benign tumor of fat "  It represents the most mesenchymal

tumor, however most of them occur in the trunk and extremities – Head and Neck are less common ✧  Asymptomatic and present for several years

Page 46: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Etiology"  Hereditaryconditionlikefamilialmultiplelipomatosis(butnothereditary)

"  Gardenerssyndrome"  Dercum’ssyndrome

Page 47: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures"  Buccal mucosa and vestibule are the most

common sites "  >40 years; female = male "  Oral lipomas are soft nodular masses that

is sessile or pedunculated with yellow color "  Softtothetouch,usuallymovable,andaregenerallypainless.

" Small(<1cm)butcanenlarge(6cm<)" Localized,lobular,non-tender"  Semi-fluctuant" Mobile

Page 48: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

DDXFibrosarcomasHerniaspapillomaNeurofibromasAbscessSebaceouscystEpidermoidcyts

Page 49: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment

• conservative local excision

Page 50: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Fibrosarcoma

Isamalignantmesenchymaltumourderivedfromfibrousconnec*ve*ssuecharacterizedbythepresenceofimmatureprolifera*ngfibroblastsorundifferen*atedanaplas*cspindlecellsinastoriformpalern.Itisusuallyfoundinmalesaged30to40.Itoriginatesinfibrous*ssuesoftheboneandinvadeslongorflatbonessuchasfemur,*bia,andmandible.Italsoinvolvesperiosteumandoverlyingmuscle

Page 51: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Etiology"  Unknownornodefinecauses"  Mayberelatedtogeneticmutation"  Ascomplicationofotherconditions

Page 52: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures➢ Nosexpredilec*on➢ Commontumorsofadults,althoughtheycanoccurinanyagegroup

andevenbepresentascongenitalneoplasms.Microscopic➢ Thecellsarearrangedinfasciclesthatintersecteachotheratacute

angles,resul*nginaherringboneappearance.➢ Theindividualcellsresemblenormalfibroblasts,andare*culinstain

demonstratesabundantfiberswrappedaroundeachcell.

Page 53: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Differentialdiagnosis

"  Monophasicsynovialsarcoma,"  Liposarcoma,"  Malignantfibroushistiocytoma,

Diagnosis• Incisionalorexcisionalbiopsy

Page 54: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment"  Geneticandimmunohistochemicaltesting"  Surgicalresection(standardtx)"  chemotherapy(notbeenencouraged)

Page 55: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

VASCULARTUMORS•  Heamangioma…...benigntumor•  Lymphangioma…..benigntumor

Page 56: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Hemangioma"  Benigntumorsofmesenchymalcells

➢ Hemangiomasarethemostcommontumorsoftheheadandneckininfancyandchildhood,

➢ Comprisingapproximately7%ofallbenignso)*ssuetumors.

"  Etiology…..congenital

Page 57: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

classificationcongenitalhemangiomacavernoushemangiomacapillaryhemangiomacentralhemangioma

Page 58: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures ➢ Most common tumors of infancy

➢ More common in females (3:1)

➢ Most common in Head and Neck (60% of

cases) ➢ Mostly occurs as single lesions

➢ Red/blue lesions that occur in skin, lips,

tongue and buccal mucosa; ➢ The lesion blanches when compressed

➢ Intraosseous lesions also occur – Mandible >

Maxilla and occurs as multilocular radiolucency

Page 59: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

DDXMacularstainsVascularmalformationPyogenicgranuloma

Page 60: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Investigation

➢ Imagingtechniques(CTscanandMRI)areusedasdiagnos*caidstodocumenttheextentofthedeephemangioma.

➢ Arteriographyisrarelyindicatedforthediagnosisofahemangioma.

Page 61: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment

"  Most congenital lesions will involute

(“Watchful Neglect”) ➢ Surgical removal and sclerotherapy with 95%

ethanol ➢ Corticosteroid medication

➢ Laser treatment

➢ Medicated gel

Page 62: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Lymphangioma Definition

•  Benign hamartomatous tumors of lymphatic vessels

• Most frequent site in the oral cavity - anterior 2/3 of the tongue where it causes MACROGLOSSIA

• Pebbly surface resembling cluster of translucent vesicles (similar to frog eggs)

Page 63: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Etiology"  Lympha*csystemblockage

-maternalalcohol,viralinfec*on"  Gene*cdisorder

Page 64: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Classification:

• Capillarylymphangioma-Capillarylymphangiomaarecomposedofsmall,capillary-sizedlympha*cvesselsandarecharacteris*callylocatedintheepidermis.

• Cavernouslymphangioma-Composedofdilatedlympha*cchannels-Characteris*callyinvadesurrounding*ssues.

Page 65: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

✓ Cys*chygromas✓ Cys*chygromasarelarge,macrocys*clymphangiomasfilledwithstraw-colored,protein-richfluid.

✓ Hemangiolymphangioma✓ Hemangiolymphangiomaarelymphangiomawithavascularcomponent.

.

Page 66: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Cyst’ssizebasedclassificationAccordingtothesizeoftheircysts.

➢ Microcys*clymphangioma➢ Microcys*clymphangiomaarecomposedofcysts,eachofwhichmeasureslessthan2cm3involume.

➢ Macrocys*clymphangioma➢ Macrocys*clymphangiomacontaincystsmeasuringmorethan2cm3involume.

➢ Mixedlymphangioma➢ Lymphangiomaofthemixedtypecontainbothmicrocys*candmacrocys*ccomponents

Page 67: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

"  Predilection to the head and neck with 50 – 75% occurring "  Cavernous lymphangiomas are most

common in oral cavity "  Thesemalformationscanoccuratanyageandmayinvolveanypartofthebody"  But,90%occurinchildrenlessthan2yearsofageandinvolvetheheadandneck.

Page 68: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Vasculartumors✓ Lymphangiomaofso)*ssueshowingdilatedspaceslinedbyflalenedendothelium.

✓ Ascaleringoflymphocytesispresentinstroma

Page 69: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Vasculartumors

Treatment• surgery• sclerotherapy

Page 70: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

TUMORSOFNERVETISSUES•  Neurofibroma•  Neurofibromatosis•  Trauma2cneuroma

Page 71: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssuesA.NeurofibromaDefinition o BenigntumorarisingfromCTofnervesheath.o Horizontalmobilityonly.o  Mostcommon

Page 72: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..o Consistsofneural(ectodermal)&fibrous(mesodermal)elements.

o Benigno Single/mul*pleo Fusiformswellinginthedirec*onofnerve

Page 73: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..•  Sites•  Cranial•  Spinal•  peripheral

Page 74: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..

Typesofneurofibroma•  Nodular•  Plexiform•  Generalised•  Elephan*a*c•  Pachydermatocoele

Page 75: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues..ctd..

Nodularo Commonlyaffectsperipheralnerveso Adultso Single,smooth,firmo Movesperpendiculartothedirec*onofthenerve.o Presentsaspainfulsubcutaneousnodule.o Skincanbeli)edup.

Page 76: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..Plexiform• Cangrowfromnervesintheskinor• Frommoreinternalnervebundles,&canbelarge• Skincanbeli)edup.• Tinglingparesthesia• Obstructsvision• Erodesintobone,orbit&deeperstructures• Myxomatousdegenera*on

Page 77: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..

Page 78: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..

Generalized✓ AkavonRecklinghausen’sdisease✓ Inheritedautosomaldisease✓ 1in4000births✓ 2types-

– Type1-chr.17muta*on– Type2-chr.22muta*on

Page 79: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..•  So),non-tender,mul*ple•  Skeletaldeformi*es•  Neurologicaldisturbance•  Caféaulaitspots•  Lischnodules•  MaybeassociatedwithMENtype2b

Page 80: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..

Page 81: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..

Page 82: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..Elephan2a2c❖ Advancedstageofplexiformvariety❖ Involveslimbs❖ Dry,coarse,thickskin❖ Congenitalorigin

Page 83: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..Pachydermatocele•  VariantofplexiformNF•  Neckisinvolved

Page 84: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..

TreatmentExcision-❑ Symptoma*c❑ Cosme*c❑ Recentincreaseinsize❑ Malignanttransforma*on

Page 85: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..B.NEUROFIBROMATOSISDefinition ANeurofibromatosisisanautosomaldominantgene9cally-inheriteddisorderinwhichthenerve9ssuegrowsabnormallytoformtumors(neurofibromas)thatmaybebenignormaycauseseriousdamagebycompressingnervesandother9ssues

Page 86: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..•  Affectsallneuralcrestcells(Schwanncells,melanocytesandendoneurialfibroblasts).

•  Melanocytesalsofunc*onabnormallyinthisdisease,resul*ngindisorderedskinpigmenta*onandcaféaulaitspots.

•  Approximatelyhalfofcasesareduetodenovomuta*onsandnootheraffectedfamilymembersareseen.

•  Itaffectsmalesandfemalesequally.

Page 87: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..NEUROFIBROMATOSISTYPE1(vonRecklinghausendisease)

•  Mul*systemneurocutaneousdisorder•  Mostcommonphakomatosis•  MostcommoninheritedCNSdisorder,autosomaldominateddisorder

•  1:3000,M:F•  50%inherited,50%spontaneous

Page 88: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..•  ThediagnosisofNF1ismadeifanytwoofthefollowing7criteriaaremet:

•  1.Twoormoreneurofibromasonorundertheskin,oroneplexiformneurofibroma(alargeclusteroftumorsinvolvingmul*plenerves)

Page 89: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..•  2.Freckling(crowesign)ofthegroinortheaxilla2-3mmindiam.3.Caféaulaitspots:(HallmarkofNF1)-Sixormoremeasuring5mmingreatestdiameterinprepubertalindividualsandover15mmingreatestdiameterinpostpubertalindividuals.

Page 90: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..

•  4.Lischnodules(hamartomasofiris),frecklingintheiris-2ormore5.Tumorsontheop*cnerve,alsoknownasanop*cglioma

Page 91: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..•  6.Adis*nc*veosseouslesionsuchassphenoiddysplasiaorcor*calthinningoflongboneswithorwithoutpseudoarthrosis.

•  7.Afirstdegreerela*vewithNF1whosediagnosiswasbaseduponthesecriteria.

Page 92: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..Signandsyndrome•  Macrocephalyin30-50%ofthepediatricpopula*onwithoutanyhydrocephalus

•  Epilepsy(seizures)•  Juvenileposteriorlen*cularopacity•  Scoliosiswithorwithoutkyphosis•  Hydrocoele•  Earlypuberty

Page 93: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..Neurofibromatosistype2(NF2)•  Alsocalled"centralneurofibromatosis“•  Isresultsfrommuta*onofthemerlin(alsoknownas"schwannomin")inchromosome22q12.i.eNF2gene

•  Itaccountsforonly10%ofallcasesofNF

Page 94: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..Thedisordermanifestsinthefollowingfashion:1. Bilateralacous9cneuromas:❖ Tumorsoftheves*bulocochlearnerveorcranialnerve8(CNVIII)alsoknownasschwannoma)

❖ ThehallmarkofNF2ishearinglossduetoacous*cschwanoma.

Page 95: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..2.

– headache– balanceproblems,andperipheralver*goduetoschwannomaandinvolvementoftheinnerear

–  facialweakness/paralysisduetoinvolvementorcompressionofthefacialnerve.

–  braintumors,aswellasspinaltumors.– deafnessand*nnitus

Page 96: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..Diagnosis•  FetusChorionicvillussamplingoramniocentesiscanbeused•  MRI•  Slitlamp

Page 97: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..Treatment•  Thereisnocureforthecondi9onsotheonlytherapyforpa9entswithneurofibromatosisistomanagesymptomsorcomplica9ons.

•  Surgerymaybeneededwhenthetumorscompressorgansorotherstructures.

•  Lessthan10%ofpeoplewithneurofibromatosisdevelopcancerousgrowths;inthesecases,chemotherapymaybesuccessful.

•  Gene9cscreeningandcounsellingforfamilieswithneurofibromatosis.

Page 98: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd..

C.Trauma2cneuroma➢ Akaamputa*ontraumaorpseudotrauma➢ Isatypeofneuromawhichresultsfromdamagetothenerve,usuallyduringsurgicalprocedures

➢ Morethan50%oftheselesionsarerelatedtotoothextrac*on

Themostcommonoralloca*on:➢ Tongue&➢ Closetomentalforamenofthemouth

Page 99: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

"   Reactive proliferation of neural tissue after damage to

nerve bundle "   Smooth nodules most common in mental foramen,

tongue and lower lip with a history of trauma; intraosseous lesions appear as radiolucencies

"  Any age but mostly middle-age, with F>M

"  Hallmark is PAIN which could be intermittent or constant

and mild or severe; "  Mental nerve neuromas are painful especially with denture

flange impingement

Page 100: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd.Classifica*onTwomajorcategories:(i)Spindleneuromasareinternal,focal,fusiformswellingssecondarytochronicfric*onorirrita*ontoanondisrupted,injuredbutintactnervetrunk.•  ii)Lateralorterminalneuromas

aretheresultofseveretraumawithdisrup*onortotaltransec*onofanerve

Page 101: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd.

Clinicalfeatures•  Trauma*cneuromasappeargrosslyasfirm,oval,whi*shnodulesthatarerarelylargerthan2cm.

•  Atsec*oning,theyhaveadensefibrousappearancewithlillevascularity.

•  Anervemayterminateattheupperpoleofthemass.

•  Althoughnotencapsulated,theouterlayeroffibrous*ssueiso)eninseparablefromthesurroundingscar,andmicroscopically,anouterlayerofconnec*ve*ssueiscon*nuouswiththeperineuriumoftheintactnervetrunk

Page 102: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd.

Differen*aldiagnosisPalisadedencapsulatedneuroma

Page 103: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tumorsofnerve*ssues…ctd.

TreatmentLymphadenectomy•  Neckdissec*on,orcervicallymphadenectomy,isaprocedureforeradica*ngmetastasestotheregionallymphnodes

Page 104: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

• SALIVARYGLANDDISEASES&TUMORS

Page 105: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

✧  Salivaryglanddiseases-Developmental-Func*onal-Inflammatory-Cystsandtumors-Miscellaneous

SALIVARYGLANDTUMORS✧ Pleomorphicadenoma✧ Adenocarcinoma✧ Warthin’stumor✧ Adenoidcys2ccarcinoma✧ Mucoepidermoidcarcinoma

Page 106: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Salivaryglanddiseases

A)Developmentaldisorders•  Aberrancy•  Aplasia&Hypoplasia•  Hyperplasia•  Atresia•  Accessoryducts•  Diver*culi•  Congenitalfistula

Page 107: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

B)Functionaldisorders

•  Sialorrhoea

•  Xerostomia

Page 108: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

C)Obstructivedisorders

•  Sialolithiasis

•  Mucusplug•  Stricture&stenosis•  Foreignbodies•  Extraductalcauses

Page 109: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

D)Cyst•  Mucocele•  Ranula

E)Asymptoma*cenlargement•  Sialosis•  Allergic•  Associatedwithmalnutri*onandalcoholism

Page 110: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Inflammatory

F)Infec*on•  Viral•  Bacterial•  Myco*cG)Autoimmunedisorders•  Sjogren’ssyndrome•  Mikulicz’sdisease•  Uveoparo*dfever•  Recurrentnonspecificparo**s

Page 111: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Developmentalanomalies

Aberrantsalivaryglands•  Anaberrantorectopicissalivarygland*ssuethatdevelopsatasitewhereitisnotnormallyfound.

Page 112: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

"   Site–cervicalregionneartheparotidglandorbodyofmandible.

Posteriortofirstmolar"   Clinicalsignifance-Sitefordevelopmentofretentioncystorneoplasm

Page 113: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Aplasia&hypoplasia

Itiscongenitallyabsenceofsalivarygland.•  Aplasiaoccursincombina*onwithcongenital

anomalies.•  Hypoplasiainpa*entwithMelkersenRosenthal

syndrome.

Page 114: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

"   Oneorgroupofglandsmissingunilaterallyorbilaterally.

" Xerostomia"   Dentalcaries"   Earlylossofteeth"   Dry&smoothoralmucosa"   Cracking&Fissuringatcornerofmouth.

Page 115: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Management"   Goodoralhygiene.

Page 116: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Functionaldisorders

SialorrhoeaorptyalismItisincreasesalivarysecre*on.S*mula*onofparasympathe*ccausesprofusesecre*onofwaterysaliva.

Page 117: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

EtiologyDrugslikesialogogues

"   LocalfactorsANUG,erythemamultiforme"   Systemiclikeparalysis"   Misc.likemetalpoisoning

Page 118: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

Droolingfrommouth•  Lipchapping•  Infec*onfromconstantexposuretosaliva•  Cheekscarring.

Page 119: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Management"   Oralmotordraining"   Biofeed"   Removaloflocalfactors"   Anticholinergicdrugs(atropinesulphate0.4mginadults.01mg/kginchildrenupto0.4"   Surgery

Page 120: ORAL CANCERS BY Dr. SINTAYEHU SIRINO
Page 121: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Sialadenitis(sialoadenitis)

ü  isinflamma*onofasalivarygland.

•  Itmaybesubdividedtemporallyintoacute,chronicandrecurrentforms

Page 122: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

AcutePredisposingfactors

•  sialolithiasis•  decreasedflow(dehydra*on,post-opera*ve,drugs)

•  poororalhygiene•  exacerba*onoflowgradechronicsialoadeni*s

Page 123: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

•  Painfulswelling•  Reddenedskin•  Edemaofthecheek,Periorbitalregionandneck•  lowgradefever•  malaise•  raisedESR,CRP,leucocytosis•  purulentexudatefromductpunctum

Page 124: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

chronic

Chronicsclerosingsialadenitis

ClinicalFeatures•  unilateral•  mildpain/swelling•  commona)ermeals•  ductorificeisreddenedandflowdecreases•  mayormaynothavevisible/palpablestone.•  Paro*dglandRecurrentpainfulswellings•  Submandibulargland•  Usuallysecondarytosialolithiasisorstricture

Page 125: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment

•  Inchronicrecurrentsialadeni*sorchronicsclerosingsialadeni*s,acutealacksaremanagedwithconserva*vetherapiessuchashydra*on,analgesics(mainlyNSAIDs),sialogoguestos*mulatesalivarysecre*on,andregular,gentleglandmassage.

•  Ifinfec*onispresent,appropriateculturesshouldbeobtained,followedbyempiricalan*bio*ctherapyini*ally,forexampleamoxicillin/clavulanateorclindamycinwhichcoveroralflora.

•  Iftherearealacksmorethanapproximately3*mesperyearorseverealacks,surgicalexcisionoftheaffectedglandshouldbeconsidered

Page 126: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

ViralInfections

MumpsContagiousviralinfec*oncausedbyparamyxovirus

Page 127: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

Unilateral&bilateralswellingofsalivarygland"   Fever,malaise,anorexia."   Tender&painoneatingsorefood"   Involvedglandcontinuestoenlargefor2-3days&

comesbacktonormal.Complicationoophritis,orchitis,meningitis,encephalitis.

Page 128: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Management

"   Selflimiting"   MMRvaccine"   Systemiccorticosteroids

Page 129: ORAL CANCERS BY Dr. SINTAYEHU SIRINO
Page 130: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Sarcoidosisheerdfordtsyndrome

•  Akauveoparo*dfever

•  Araremanifesta*onofsarcoidosis

Page 131: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

symptoms:

Includeinflammationoftheeye(uveitis),swellingoftheparotidgland,chronicfever,andinsomecases,palsyofthefacialnerves.

Page 132: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Causes

•  TheexactcauseofHeerfordt'ssyndromehasnotyetbeendefini*velydetermined.

•  Ofthosepa*entswhohavebeendiagnosedwithHeerfordt'ssyndrome,15%haveacloserela*vewhoalsohasthesyndrome.

•  Onepossibleexplana*onisthatthesyndromeresultsfromacombina*onofanenvironmentalagentandahereditarypredisposi*on.

•  MycobacteriumandPropionibacteriaspecieshavebothbeensuggestedastheenvironmentalagent,thoughtheevidenceforthisisinconclusive.

Page 133: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Diagnosis

•  Inpa*entsthathavealreadybeendiagnosedwithsarcoidosis,Heerfordt'ssyndromecanbeinferredfromthemajorsymptomsofthesyndrome,whichincludeparo**s,fever,andfacialnervepalsy.

•  Incasesofparo**s,ultrasound-guidedbiopsyisusedtoexcludethepossibilityoflymphoma.

•  Therearemanypossiblecausesoffacialnervepalsy,includingLymedisease,HIV,Melkersson–Rosenthalsyndrome,schwannoma,andBell'spalsy.

•  Heerfordt'ssyndromeexhibitsspontaneousremission.

Page 134: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatments

•  Cor*costeroidsandimmunosuppressivedrugs.

Page 135: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

NecrotizingSialometaplasia

• Uncommonlocallydestruc*veinflammatorycondi2onofthesalivaryglands.

Cause:•  unknownbuttheybelieveitistheresultofischemiaofthesalivary*ssuethatleadstolocalinfac2on.

Page 136: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

ISCHEM

IA

OXYGEN

Page 137: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Predisposingfactors:

– Trauma*cinjuries– Dentalinjec*ons– Illfirngdentures– Upperrespiratoryinfec*ons– Adjacenttumors– Previoustumors***Howevermanycasesoccurwithoutany

knownpredisposingfactors.

Page 138: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

CLINICALFEATURES

✓ Mostfrequentlydevelopsinthepalatalsalivaryglands✓ Hardpalate>so)palate✓ 2/3ofpalatalcasesareunilateral,withtherestbeingbilateralormidlineinloca2on

Page 139: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

CLINICALFEATURES

• Hasalsobeenreportedinotherminorsalivaryglandsitesandoccasionallyintheparo*dgland.

• Submandibularandsublingualglandsarerarelyaffected.

Page 140: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

CLINICALFEATURES

• Mostcommoninadultsandinmen

•  Thecondi*onappearsini*allyasanon-ulceratedswellingo)enassociatedwithpainorparesthesiawithcrater-likeulcerthatcanrangefromlessthan1cmtomorethan5cmindiameterappearingwithin2to3weeks.

Page 141: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

CLINICALFEATURES

Page 142: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Bilateral

Midlineinloca*on

Page 143: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Unilateral

Page 144: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment

• Thelesionisself-limi*nginmostinstancesandhealsunevenuully.

Page 145: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

autoimmunediseases

Sjorgen’ssyndrome•  Chronicinflammatorydiseasethatpredominantlyaffects

salivary,lacrimal&otherexocrineglands•  ItwasfirstdescribedbyHENNIKSJOGRENin1933.

Page 146: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Types

primary–dryeyes,drymouth.secondary–dryeyes,drymouth,collagendisordersusuallyrheumatoidarthritis&SLE.

Page 147: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Salivaryglanddiseases

Page 148: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

ClinicalFeatures

•  Middleagedandfemalearecommonly

infected•  Xerostomia•  Sorenessanddifficultyincontrollingdentures•  Pusfromduct•  Difficultyinea2ngandunpleasanttaste•  Unilateralandbilateralenlargementofparo2dgland

•  Frothysaliva•  Severedentalcaries•  Depapilla2onoftongue•  Dryeyes•  Vaginaldryness•  Connec2ve2ssuedisorder•  Enlargementoflymphnodes

Page 149: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

RadiographicFindings"   Snowstormappearance

"   Insomecasescherryblossomappearance

Page 150: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

MANAGEMENT

SYMTOMATICTREATMENT" Occularlubricant-artificialtearscoatingmethyl

cellulose

"   Salivasubstitute"   Oralhygiene

"   Surgeryforenlargementofglands

Page 151: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

MIKULICZ’SDISEASE•  Symmetricorbilateralchronicpainless

enlargementoflacrimalorsalivaryglandhasinflammatorycharacteris*cs.

Page 152: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

ClinicalFeatures

Womeninmiddleandlaterlife"   Site-unilateralorbilateralenlargementofparotidor

submandibulargland"   Fever"   Upperrespiratorytractinfection"   Occasionalpain" Xerostomia"   Diffusepoorlyoutlineandenlargementofgland

Page 153: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Management

Surgicalexcision

Page 154: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Investigations

Non-invasiveinves*ga*ons

•  Radiographs•  ComputerizedTomography•  Ultrasoundscanning•  Magne*cresonanceimaging•  SinglePhotonemissionComputedTomographyInvasiveInves*ga*ons•  Biopsy•  FineneedleAspira*oncytologySialography

Page 155: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

SALIVARYGLANDTUMORS

Page 156: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

SALIVARYGLANDTUMORS

Classifica*onoftumorsBenign✧ Pleomorphicadenoma✧ Warthin’stumor✧ Ductalpapillomas✧ Basalcelladenoma✧ Canalicularadenoma✧ oncocytoma

Page 157: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Benign tumors

✓ Painless ✓ Slow growing ✓ No facial palsy

Page 158: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Epidemiology

•  Rule of 80’s •  Mucoepidermoid – MC

malignancy1.2%ofallneoplasms

Page 159: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Malignant

MucoepidermoidcarcinomaAdenocarcinomaAdenoidcys*ccarcinomaAciniccellcarcinomaSquamouscellcarcinoma

Page 160: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Indications of malignancy

•  Facial nerve involvement

•  Indurations / ulceration of skin , mucous membrane

•  Lymph node metastasis

•  Rapid tumor growth

Page 161: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Investigations

o FNAC

o Open biopsy

o CT

o MRI

Page 162: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Pleomorphicadenoma

•  Commonest benign tr

•  Pseudocapsule

•  Pseudopodal extensions •  Not multicentric

Page 163: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

Age—anyagebutmorecommonb/n30-50yrs

Sex--women

Site–post.hardpalate&ant.softpalatemucosafollowedbyupperlip&buccalmucosa

Page 164: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

•  Mixed tumor

•  Consists of cartilage besides epithelial cells

•  Cartilage not of mesodermal

origin •  Derived from mucin secreted by

epithelial cells

Page 165: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Diagnosis

•  Lobulated,painlessswelling

•  Longdura*on

•  Neitheradherenttoskin/massetermuscle

•  Generallyfirm/variableconsistency

Page 166: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

DDx

Otherbenignandmalignantsalivaryglandtumors

Ø  Necrotisingsialadenometaplasia

Ø  Lipoma

Page 167: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Malignanttransformation•  3 – 5 % of cases

•  Pain

•  Rapid growth •  Hard •  Fixed to masseter

•  Fixity to skin

•  Lymph nodes •  Restricted jaw movements

Page 168: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tx

•  Superficial parotidectmy

•  Total parotidectomy

Page 169: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Warthin’stumor

(Papillary cystadenoma lymphamatosum)

•  Abenigncys2ctumor•  containsabundantlymphocytes&germinalcenters(LN-

likestroma)•  5 – 15 % of parotid trs

•  Always at the lower pole of the parotid •  Overlies the angle of mandible Etiology unknown ,smoking

Page 170: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

•  More in white races

•  Not seen in negroes

•  Encapsulated lesions •  No malignant transformation

Page 171: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

•  Only salivary neoplasm more in males

•  Elderly males

•  Slow growing •  painless

Page 172: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

•  Surface is smooth •  Well defined •  Distinct margins •  Soft in consistency with

fluctuation •  Not tansilluminant

Page 173: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Investigation

•  FNAC Tc99 scan – hot spot DDX •  Sebaceous lymphadenoma •  oncocytoma

Page 174: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

SALIVARYGLANDTUMORS

Tx•  Superficial parotidectmy

•  Enucleation

Page 175: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Malignanttumors

•  Commonest site –minor glands

•  Palate

•  MC in females

•  7th decade •  Previous irradiation

Page 176: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Mucoepidermoidcarcinoma

•  MC •  The tumor made up of 3 types of cell

(mucous,epidermoid,inter.)

•  Parotid &minor gland •  Slow growing tr •  Lung, bone, brain -15%

Page 177: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

epidemiology"   Occursinadult

"   Peakincidence—20-40yrs

"   CausallinkwithCMVhasbeenstronglyimplicated

Page 178: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures"   Presentas:

Ø  painless,

Ø  slow-growingmass,

Ø  w/cfirm/hard

Ø  mostappearclinicallyasmixedtumors

Page 179: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tx

✓ Determinedbythetumor:gradeLoca*onClinicalpresenta*on

Page 180: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Adenoidcysticcarcinoma

•  Malignant cylindroma •  The third MC •  Rare in parotid •  60% in sublingual gland •  Generally,slow growing and

well defferentiated

Page 181: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

•  Perineural invasion

•  Nerve palsy even before mass

•  Also spread along haversian system and

•  neural canals of bone

•  Mets LN –direct spread

Page 182: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Tx"   Surgical removal "   Fast neuron therapy "   chemotherapy

Page 183: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Adenocarcinoma

isatypeofcancerthatformsinmucussecretingglandsthroughoutthebody.

Page 184: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures"   Rare "   Mainly parotid "   80% as adherent masses "   5thto8thdecades"   F>M"   Parotidandminorsalivaryglands"   Presentation:

–Enlargingmass–25%withpainorfacialweakness

Page 185: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Dx

BoipsyCTscanMRI

Page 186: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

TxSurgery

RadiationtherapyChemotherapy

Page 187: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

HARDTISSUETUMORS

Page 188: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

NONODONTOGENICTUMORS

Page 189: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

•  Nonodontogenictumorsofthejaworigina*ngfromboneanditsmesenchymal*ssuerepresentalargegroupofdiversediseases.

Page 190: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Thefollowingprimarytumorsbelongtothisgroup;

1.  Bonetumorsa)  Benign;osteoma,osteoblastomaand

osteoidosteomab)  Malignant;osteosarcoma2.car*lagetumorsa)  Benign;chondroma,chondroblastoma,cho

ndromyxoidfibroma,osteochondromab)  Malignant;chondrosarcoma

Page 191: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

3.Fibroplas*ctumors•  Desmoplas*cfibroma•  Fibrosarcoma4.Ewingsarcoma5.Plasmocytomaandmalignantlymphoma6.Vasculartumors•  Haemangioma•  Malignantvasculartumors

Page 192: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

• OsteogenicTumorOsteoma•  (Alsorefferedtoasexostosis)almostuniquelyoccursinthecranialbones.

•  Itrepresentsahamartomatousnewgrowthconsis*ngofmedullaryorcompactbone,andpresen*ngonthesurfaceofthebonefromwhichitarises.

•  Womenaffectedmostfrequently

Page 193: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinical&RadiographicFeatures

•  slowgrowing,usuallyasymptoma2ctumor

•  periostealorendostealosteomas•  radiographically:presen2ngasaCircumscribedsclero2cmassconsistentwithbonedensitydependingonthetumorscomponent

•  canbeassociatedwithGardnerssyndrome(mul2pleosteoma,intes2nalpolyposisleadingtocolonCA)

Page 194: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Mul*pleosteomaassociatedwithgardner’ssyndrome

Page 195: ORAL CANCERS BY Dr. SINTAYEHU SIRINO
Page 196: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

HistopathologicFeatures•  Compactosteoma:densebonewithMinimalmarrow2ssue

•  Cancellousosteoma:trabeculaewithfibro-facymarrow

Page 197: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Differen*aldiagnosis

•  Cementoblastomaandcemen*fyingfibroma

Treatment&Prognosis

Donotneedtobetreated,ifnosymptom

Page 198: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Osteosarcoma

•  Malignant,osteoidproducingmesenchymaltumor;itisthemostfrequentprimarymalignantbonetumor

•  Thedistalfemurandproximal*bia;themostfrequentsites;7%occuringinthejaws

•  Menareaffectedmostfrequently

Page 199: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinical&RadiographicFeatures

•  mosto)enoccurringinthethirdandfourthdecadesoflifemales>females,swellingandpainlooseningofteeth,paresthesia,andnasalobstruc*onyoungchildrentotheelderlyvaryingfromdensesclerosistoadmixedsclero*candradiolucentlesion,toanen*relyradiolucentprocess,illdefinedandindis*nctmargin

Page 200: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

HistopathologicFeatures•  Directproofoftumorosteoidforma2onby

atypicalmesenchymalcellsisimportantfordiagnosis

•  thetumorotherwiseappearswithbothchondroiddifferen*ated(‘chondroblas*csarcoma),orfibroblas*cformsinthesametumor.

differen*aldiagnosis

•  Osteoma•  Osteoblastoma•  Ossifyingfibroma

Page 201: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Treatment&Prognosis

•  radicalsurgicalexcision•  supplemented:chemotherapy,•  radia2ontherapyorboth

Page 202: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Car*lagetumors

A.  Chondroma(benign)B.  Chondrosarcoma(malignant)

Page 203: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

1.Chondroma

•  Benigntumorsofhyalinecar*lagewithatendencyformalignantgrowth.

•  mosto)enlocatedintheshorttubularbonesofthehandandthefeet.

•  rarelybeenreportedinthejaws.HistopathologicalFeaturesmaturecar*lage,verydifficulttodis*nguishfromlowgradechondrosarcoma

Page 204: ORAL CANCERS BY Dr. SINTAYEHU SIRINO
Page 205: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

TreatmentandPrognosis

•  TotalsurgicalremovalofthetumorDifferen*aldiagnosischondrosarcoma

Page 206: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Chondrosarcoma

•  Malignantneoplasmofhyalinecar*lage.•  mostcommonlylocatedinthemetaphysealregionofthelongbones.

•  rarelyinvolvinginthejaws

Page 207: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

ClinicalandRadiographicFeature

•  wideagerange•  averageage:33years•  themostcommonpresen2ngaspainlessorswellingmass

•  themaxillaandmandibleinvolvedwithaboutequalfrequency

•  aradiolucentprocesswithpoorlydefinedborders

•  containingscaceredandvariableamountsofradiopaquefoci

Page 208: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

HistopathologicalFeatures

•  Consistsofcar2lagewithvaryingdegreeofmatura2onandcellurarity,andshowinglobulatedgrowthpacern

•  ossifica2on,calcifica2onandchondroidmatrix

Page 209: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Differen2aldiagnosis

•  Radiologically;Itishardlypossibletoclearlydis*ngushthesetumorsronmanyotherbenignormalignantgrowth.

•  Themostimportanthistologicaldifferen*a*onisfromosteosarcomasincethismayshowextensivechondroiddifferen*atedparts

Page 210: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

TreatmentandPrognosis

•  Radicalsurgicalexcision•  Poorerprognosisthanosteosarcomaofthejaws

Page 211: ORAL CANCERS BY Dr. SINTAYEHU SIRINO
Page 212: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Vasculrtumors

•  Bothbenignandmalignantvasculartumorsrarelyoccurinthejaw

centralhaemangioma•  isabenignvasculartumorrarelyoccuringinthejaw.

•  itoccursmorefrequentlyinwomenandinthemaxilla.

Page 213: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

•  Asymptoma*cswelling,occasionallooseningoftheteethandhaemorrhagefromaroundtheneckofthetooth.

diagnosis/histologicalfindings•  Poorlydemarcatedosteolysis•  Usuallycapillaryhaemangiomas,somewithcavernousspread

Page 214: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Differen*aldiagnosis

•  Otherosteoly*clesiontreatmentandprognosis•  Toothextrac*onmaycauseseverehaemorrhage;angiographyincaseofsuspicion

•  resec*on

Page 215: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Centralgiantcelltumor

•  Itisrela*velyuncommontumorofbone.•  Itischaracterizedbytheprescenceofmul*-nucleatedgiantcells(osteoclastlikecells).

•  Inmostpa*ents,thetumorsareslowtodevelop,butmayrecurlocallyinasmanyas50%ofthecases.

Page 216: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Clinicalfeatures

•  Painandlimitedrangeofmo*oncausedbytumor’sproximitytothejointspace

•  Swelling•  Muscularachesandpaininarms,legsandabdominalpain

Page 217: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Diagnosis

•  Presenceofmul*nucleatedgiantcells•  Surroundingmononuclearandsmallmul*nucleatedcellshavenucleisimilartothoseinthegiantcells

•  SoapbubbleappearanceTreatment•  Surgery•  curelage

Page 218: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

Differen*aldiagnosis

•  Aneurysmalbonecyst•  Chondroblastoma•  Simplebonecyst•  Osteoidosteoma•  Osteoblastoma•  osteosarcoma

Page 219: ORAL CANCERS BY Dr. SINTAYEHU SIRINO

THANKYOU